Identification of potential biomarkers for SLE through mRNA expression profiling

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disorder affecting multiple organ systems.
• Furin, tristetraprolin (TTP), and NOD, LRR, and pyrin domain-containing protein 3 (NLRP3) are implicated in the pathogenesis of autoimmune diseases.

Purpose of the Study:

• To investigate the role of furin, TTP, and NLRP3 mRNA gene expression in the pathogenesis and prognosis of Systemic Lupus Erythematosus (SLE).

Main Methods:

• A case-control study involving 210 participants (105 SLE cases, 105 controls).
• Real-time quantitative PCR was employed to measure mRNA gene expression levels of furin, TTP, and NLRP3 in all subjects.

Main Results:

• SLE patients exhibited significantly elevated serum furin and NLRP3 mRNA expression compared to controls (p < 0.001 and p = 0.006, respectively).
• Conversely, TTP mRNA expression was significantly lower in SLE patients than in controls (p < 0.001).
• Elevated furin and NLRP3 levels, along with decreased TTP levels, were associated with increased SLE disease activity.

Conclusions:

• Furin and NLRP3 gene expression are upregulated in SLE and correlate positively with disease activity.
• TTP gene expression is downregulated in SLE and shows a negative correlation with disease activity.